UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

The Journal of immunology (1950), 2010-08, Vol.185 (4), p.2273-2284

2010

Volltextzugriff (PDF)

Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6442

2021

Volltextzugriff (PDF)

Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy

Journal of immunotherapy (1997), 2013-11, Vol.36 (9), p.477-489

2013

Volltextzugriff (PDF)

Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes

Nature communications, 2019-02, Vol.10 (1), p.713-713, Article 713

2019

Volltextzugriff (PDF)

IL-13 is produced by tumor cells in breast implant–associated anaplastic large cell lymphoma: implications for pathogenesis

Human pathology, 2018-08, Vol.78, p.54-62

2018

Volltextzugriff (PDF)

Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations

Proceedings of the National Academy of Sciences - PNAS, 2017-04, Vol.114 (15), p.3975-3980

2017

Volltextzugriff (PDF)

Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines

Journal of translational medicine, 2011-06, Vol.9 (1), p.90-90, Article 90

2011

Volltextzugriff (PDF)

Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma

Haematologica (Roma), 2020-05, Vol.106 (6), p.1714-1724

2020

Volltextzugriff (PDF)

Survival Signals and Targets for Therapy in Breast Implant― Associated ALK― Anaplastic Large Cell Lymphoma

Clinical cancer research, 2012-09, Vol.18 (17), p.4549-4559

2012

Volltextzugriff (PDF)

Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation

Cellular & molecular immunology, 2019-02, Vol.16 (2), p.138-153

2019

Volltextzugriff (PDF)

Spatio-temporal biodistribution of 89Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor model

Scientific reports, 2021-07, Vol.11 (1), p.1-13, Article 15077

2021

Volltextzugriff (PDF)

A Hybrid Protein–Polymer Nanoworm Potentiates Apoptosis Better than a Monoclonal Antibody

ACS nano, 2014-03, Vol.8 (3), p.2064-2076

2014

Volltextzugriff (PDF)

The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1

Frontiers in endocrinology (Lausanne), 2022-11, Vol.13, p.1051988

2022

Volltextzugriff (PDF)

Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins

Journal of Immunology Research, 2016-01, Vol.2016 (2016), p.1-9

2016

Volltextzugriff (PDF)

Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma

Oncoimmunology, 2021-01, Vol.10 (1), p.1838140-1838140

2021

Volltextzugriff (PDF)

Expression of the luteinizing hormone receptor (LHR) in ovarian cancer

BMC cancer, 2019-11, Vol.19 (1), p.1114-1114, Article 1114

2019

Volltextzugriff (PDF)

Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2

Cancers, 2021-01, Vol.13 (2), p.212

2021

Volltextzugriff (PDF)

Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes

Molecular therapy, 2022-09, Vol.30 (9), p.3066-3077

2022

Volltextzugriff (PDF)

Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy

Molecular therapy, 2020-02, Vol.28 (2), p.536-547

2020

Volltextzugriff (PDF)

Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma

International journal of molecular sciences, 2017-12, Vol.18 (12), p.2773

2017

Volltextzugriff (PDF)

Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases

Plastic and reconstructive surgery (1963), 2015-03, Vol.135 (3), p.695-705

2015

Volltextzugriff (PDF)

PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells

Scientific reports, 2017-07, Vol.7 (1), p.6594-14, Article 6594

2017

Volltextzugriff (PDF)

Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations

Antibodies (Basel), 2020-06, Vol.9 (2), p.22

2020

Volltextzugriff (PDF)

Targeting macrophages for enhancing CD47 blockade–elicited lymphoma clearance and overcoming tumor-induced immunosuppression

Blood, 2022-06, Vol.139 (22), p.3290-3302

2022

Volltextzugriff (PDF)

MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro

Clinical cancer research, 2014-12, Vol.20 (23), p.6034-6044

2014

Volltextzugriff (PDF)

1 – 25 von 477

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(419)
Mit Volltextzugriff
(384)

Publikationsform

Sprache

Englisch
(475)
Japanisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(25)
The Journal Of Urology
(20)
Urology
(19)
Cancer
(15)
Clinical Cancer Research
(15)
Blood
(13)
The Journal Of Immunology
(11)
Cancer Biotherapy & Radiopharmaceuticals
(10)
Journal Of Immunotherapy
(10)
Pediatric Research
(9)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives

Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy

Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes

IL-13 is produced by tumor cells in breast implant–associated anaplastic large cell lymphoma: implications for pathogenesis

Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations

Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines

Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma

Survival Signals and Targets for Therapy in Breast Implant― Associated ALK― Anaplastic Large Cell Lymphoma

Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation

Spatio-temporal biodistribution of 89Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor model

A Hybrid Protein–Polymer Nanoworm Potentiates Apoptosis Better than a Monoclonal Antibody

The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1

Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins

Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma

Expression of the luteinizing hormone receptor (LHR) in ovarian cancer

Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2

Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes

Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy

Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma

Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases

PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells

Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations

Targeting macrophages for enhancing CD47 blockade–elicited lymphoma clearance and overcoming tumor-induced immunosuppression

MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro

Suchergebnisse filtern